Clear Street’s YD Bio Ltd YDES Stock Holding History

Clear Street’s Portfolio YDES Stock Details YDES Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,500	Closed	-$146K	–	1052
2025 Q3	$146K	Buy	+7,500	New	+$130K	﹤0.01%	371

Other funds holding YDES

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

CCMW

Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Clear Street's YDES Position: Q4 2025 in Review

Clear Street sold out of YD Bio Ltd (YDES) in Q4 2025, closing a stake of 7,500 shares — an estimated $146K sold.

Clear Street first reported a position in YDES in Q3 2025 and held it in 1 quarter. The position peaked at $146K in Q3 2025. 10 funds tracked by Wall St. Rank hold YDES as of Q4 2025.

Clear Street reported no remaining YD Bio Ltd position as of Q4 2025 after selling out during the quarter.
Clear Street sold 7,500 YD Bio Ltd shares in Q4 2025, an estimated $146K.
Clear Street first reported a position in YD Bio Ltd in Q3 2025 and held it in 1 quarter.
Clear Street's YD Bio Ltd position peaked at $146K in Q3 2025.
10 funds tracked by Wall St. Rank held YD Bio Ltd as of Q4 2025.

Based on Clear Street's 13F filing for Q4 2025, filed 13 Feb 2026.